TP: Clinical Trials

6 trials of TP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 unknown. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Unknown 3
Phase 21Completed 1

Follow TP: new trials by email Literature Review of TP trials Research Report on TP

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma
Camrelizumab plus TP, TP - Oral Squamous Cell Carcinoma
Phase 3UnknownHospital of Stomatology, Wuhan University3092023-11-212024-04-02
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
Doxorubicin Hydrochloride Liposome Injection+carboplatin, paclitaxel +carboplatin - Ovarian Cancer
Phase 3UnknownHunan Cancer Hospital3382017-08-012021-04-08
A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer
Paclitaxel and Cisplatin, Paclitaxel and Fluorouracil, Paclitaxel and Carboplatin - Stage III Esophageal Squamous Cell Carcinoma
Phase 3CompletedFudan University3212015-07-012022-02-09
Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
cisplatin and paclitaxel - Esophageal Neoplasm
Phase 3CompletedHenan Cancer Hospital5282015-06-012022-10-05
A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
nedaplatin and docetaxel, cisplatin and docetaxel - Nasopharyngeal Carcinoma
Phase 3UnknownGuangxi Medical University22011-11-012011-11-28
Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer
EC-T, TP - Breast Cancer
Phase 2 / Phase 3CompletedChinese Academy of Medical Sciences3202009-06-012021-02-09

Conditions studied

Breast Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Ovarian Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Chinese Academy of Medical Sciences (1)  ·  Fudan University (1)  ·  Guangxi Medical University (1)  ·  Henan Cancer Hospital (1)  ·  Hospital of Stomatology, Wuhan University (1)  ·  Hunan Cancer Hospital (1)

Countries

China (6)

Top investigators

Gang Chen, M.D. (1)  ·  Jing Wang, MD. (1)  ·  Kuaile Zhao, MD (1)  ·  Peng Yuan, MD (1)  ·  Wu Fang, M.D. (1)  ·  Yin Li, MD.&PhD. (1)

Results publications

PMID 30344165, PMID 34648118, PMID 35188552, PMID 36861447